Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report

BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Res Notes
Autors principals: Koie, Takuya, Ohyama, Chikara, Okamoto, Akiko, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://ncbi.nlm.nih.gov/pubmed/24267160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars